Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

The Experiences of Family Caregivers of Stroke Patients: A Cross-sectional Study of a French Cohort (AVCAIDE)

31. oktober 2022 oppdatert av: Groupe Hospitalier Paris Saint Joseph

Stroke is the most common cause of non-traumatic disability in adults and ranks second among causes of dementia and third among causes of death. In France, stroke affects around 140,000 patients each year and entails enormous economic costs. Given the average age of onset of stroke, its prevalence is expected to increase with increasing life expectancy and the advancing age of the population.

Clinically, depending on the region of the brain affected, stroke results in a sudden and abrupt onset of sensorimotor, cognitive, emotional and / or behavioral manifestations, associated with variable recovery from patient to patient. Stroke has psychological, social and family consequences. Indeed, its occurrence could affect patients on a physical and psychological level (direct physical and cognitive sequelae of stroke, decrease or even absence of autonomy and dependence of the entourage, associated psychological changes) and generate repercussions on the dynamics. family or that of the couple (ie, changes in activities, redistribution of tasks, changes or even inversion of roles, alteration of the intimate sphere), as well as professional and social life. This could hamper the quality of life of patients and their loved ones and cause collateral damage to their social or family environment.

After discharge from the hospital, the patient's relatives will play a major role in taking charge of home care (e.g. household activities and personal care around hygiene, food, mobility and administration. treatments) as well as in the community (eg purchase of clothes or food, accompaniment to medical visits), although these helpers do not have the professional knowledge and skills in care. Despite the positive effects that caregivers can have in connection with the care they provide (ie, feeling of accomplishment and usefulness, development of a sense linked to this helping role, better self-esteem, improvement of personal skills), their continued investment in their sick relatives could deprive them of their resources, making them "hidden or invisible patients / victims". In addition, the gap between caregiver capacities to provide care and the health needs of patients could result in caregiver burden (i.e., caregiving burden). Caregivers of stroke patients experience an impaired quality of life, neglect of their own health, reduced work and leisure activities, as well as psychological suffering involving feelings of abandonment, loneliness and helplessness. uncertainty. In the context of a stroke, caregivers may be overwhelmed by the emotions of their ill loved ones as well as their own emotions. Emotional regulation is essential in such a context rich in emotional experience; it is the set of strategies that enables individuals to influence the emotions they feel, when they appear, and how they experience and express them.

Reviews of the literature have highlighted the lack of studies addressing the burden on caregivers and the need for research to identify those at risk and implement appropriate interventions.

No French study has specifically addressed the notion of the burden of caregivers of stroke patients, their coping strategies, their experiences or emotional regulations. This type of study would however constitute a step towards the design and implementation of personalized care (eg: psychotherapies), by strengthening effective / adaptive strategies and modifying those which are less effective / poorly adaptive. This could improve the well-being of caregivers and their sick relatives, and direct health policies to reduce the economic impact of this aid.

Studieoversikt

Status

Fullført

Forhold

Studietype

Observasjonsmessig

Registrering (Faktiske)

16

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Boulogne, Frankrike, 92774
        • Institut de Psychologie, Université de Paris
    • Groupe Hospitalier Paris Saint-Joseph
      • Paris, Groupe Hospitalier Paris Saint-Joseph, Frankrike, 75014
        • Groupe Hospitalier Paris Saint Joseph

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

N/A

Kjønn som er kvalifisert for studier

Alle

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

Patients treated in the NeuroVasular Unit (UNV) of Saint-Joseph Hospital in Paris and consultant in the same department between 01/15/2021 and 05/31/2021 (usual post-stroke consultation) will be included

Beskrivelse

Inclusion Criteria:

For patients:

  • Patient whose age is ≥ 18 years
  • Patient having had a stroke
  • Patient hospitalized in UNV
  • Patient able to understand the information and no objection form
  • Patient who did not need help before the onset of stroke (retrospective evaluation with a score <2 on the Rankin scale
  • Patient having spent at least 3 months at home (directly after hospitalization in UNV or after undergoing rehabilitation)
  • Patient with sequelae upon discharge from hospital (score ≥ 2 on the Rankin scale)
  • French-speaking patient

For caregivers:

  • Caregiver whose age is ≥ 18 years
  • Caregiver of the patient with stroke
  • Being a family caregiver according to Article L. 113-1 of the Social Action and Families Code for at least 3 months and at most 12 months

Exclusion Criteria:

For patients:

  • Patient who suffered from a transient ischemic attack
  • Patient who has had two or more strokes
  • Patient with a disability before the onset of stroke (score ≥2 on the Rankin scale)
  • Patient under guardianship or curatorship
  • Patient deprived of liberty
  • Patient under legal protection
  • Patient objecting to the use of their data for this research

For caregivers:

- Helping another person at the same time.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Charge of assistance to family caregivers
Tidsramme: Month 3
This outcome corresponds to the support for caregivers using the Brief Burden Interview.
Month 3
Charge of assistance to family caregivers
Tidsramme: Month 3
This outcome corresponds to the support for caregivers using Caregiver Reaction Assessment.
Month 3

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

28. januar 2021

Primær fullføring (Faktiske)

31. mai 2021

Studiet fullført (Faktiske)

8. juli 2022

Datoer for studieregistrering

Først innsendt

3. februar 2021

Først innsendt som oppfylte QC-kriteriene

3. februar 2021

Først lagt ut (Faktiske)

5. februar 2021

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

1. november 2022

Siste oppdatering sendt inn som oppfylte QC-kriteriene

31. oktober 2022

Sist bekreftet

1. oktober 2022

Mer informasjon

Begreper knyttet til denne studien

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

3
Abonnere